NASDAQ:VIVE - Viveve Medical Stock Price, Forecast & News

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Viveve Medical Inc (NASDAQ:VIVE) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($13.51) earnings per share for the quarter, topping the Zacks' consensus estimate of ($16.00) by $2.49. The firm earned $1.05 million during the quarter. Viveve Medical had a negative net margin of 429.71% and a negative return on equity of 2,979.48%. View Viveve Medical's Earnings History.

Viveve Medical is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Viveve Medical.

6 brokerages have issued 1 year target prices for Viveve Medical's shares. Their forecasts range from $0.20 to $6.00. On average, they anticipate Viveve Medical's share price to reach $2.05 in the next year. This suggests a possible upside of 144.0% from the stock's current price. View Analyst Price Targets for Viveve Medical.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Viveve Medical.

News stories about VIVE stock have trended somewhat negative on Friday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Viveve Medical earned a news impact score of -1.7 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Viveve Medical.

Viveve Medical saw a increase in short interest in the month of November. As of November 29th, there was short interest totalling 353,600 shares, an increase of 176.5% from the November 14th total of 127,900 shares. Based on an average daily trading volume, of 1,276,500 shares, the days-to-cover ratio is currently 0.3 days. Approximately 24.6% of the company's shares are short sold. View Viveve Medical's Current Options Chain.

Some companies that are related to Viveve Medical include Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), Nexeon Medsystems (NXNN), CHF Solutions (CHFS), Reshape Lifesciences (RSLS), ReShape Lifesciences (RSLSD), Escalon Medical (ESMC), Trimedyne (TMED), Guided Therapeutics (GTHP), Magna-Lab (MAGAA), Newcardio (NWCI), Echo Therapeutics (ECTE), 21st North (ULGX), IMRIS (IMRSQ) and SpectraScience (SCIE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Fortive (FTV), HP (HPQ), Lowe's Companies (LOW), Western Digital (WDC), Viking Therapeutics (VKTX), Quantenna Communications (QTNA), SCYNEXIS (SCYX) and Foundation Medicine (FMI).

(VIVE) raised $13 million in an IPO on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager.

Viveve Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include FNY Investment Advisers LLC (1.10%). View Institutional Ownership Trends for Viveve Medical.

VIVE stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. View Insider Buying and Selling for Viveve Medical.

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VIVE stock can currently be purchased for approximately $0.84.

Viveve Medical has a market capitalization of $1.24 million and generates $18.52 million in revenue each year. The company earns $-49,320,000.00 in net income (profit) each year or ($161.00) on an earnings per share basis. Viveve Medical employs 67 workers across the globe.View Additional Information About Viveve Medical.

The official website for Viveve Medical is http://www.viveve.com/.

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]